Atria Investments LLC Abbott Laboratories Transaction History

Atria Investments LLC

  • $7.56 Billion
  • Q3 2024

A detailed history of Atria Investments LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Atria Investments LLC holds 163,218 shares of ABT stock, worth $19.2 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
163,218
Previous 153,896 6.06%
Holding current value
$19.2 Million
Previous $16 Million 16.37%
% of portfolio
0.25%
Previous 0.22%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$100.07 - $118.13 $932,852 - $1.1 Million
9,322 Added 6.06%
163,218 $18.6 Million
Q2 2024

Aug 13, 2024
SELL
$100.73 - $112.44 $960,561 - $1.07 Million
-9,536 Reduced 5.83%
153,896 $16 Million
Q1 2024

May 21, 2024
BUY
$109.52 - $120.96 $1.66 Million - $1.83 Million
15,118 Added 10.19%
163,432 $18.6 Million
Q4 2023

Feb 14, 2024
BUY
$90.19 - $110.4 $1.59 Million - $1.95 Million
17,657 Added 13.51%
148,314 $16.3 Million
Q3 2023

Nov 07, 2023
SELL
$95.53 - $114.62 $350,690 - $420,770
-3,671 Reduced 2.73%
130,657 $12.7 Million
Q2 2023

Aug 04, 2023
BUY
$100.78 - $112.29 $1.21 Million - $1.34 Million
11,966 Added 9.78%
134,328 $14.6 Million
Q1 2023

May 10, 2023
BUY
$96.86 - $114.01 $855,370 - $1.01 Million
8,831 Added 7.78%
122,362 $12.4 Million
Q4 2022

Jan 31, 2023
BUY
$95.06 - $111.52 $469,596 - $550,908
4,940 Added 4.55%
113,531 $12.5 Million
Q3 2022

Nov 01, 2022
BUY
$96.76 - $112.03 $712,637 - $825,100
7,365 Added 7.28%
108,591 $10.5 Million
Q2 2022

Aug 11, 2022
SELL
$102.07 - $123.37 $3.09 Million - $3.73 Million
-30,264 Reduced 23.02%
101,226 $11 Million
Q1 2022

May 02, 2022
BUY
$114.02 - $139.04 $1.24 Million - $1.51 Million
10,885 Added 9.03%
131,490 $15.6 Million
Q4 2021

Feb 04, 2022
BUY
$115.53 - $141.46 $1.81 Million - $2.22 Million
15,694 Added 14.96%
120,605 $17 Million
Q3 2021

Nov 16, 2021
BUY
$116.66 - $129.06 $1.83 Million - $2.02 Million
15,658 Added 17.54%
104,911 $12.4 Million
Q2 2021

Aug 10, 2021
BUY
$105.79 - $124.53 $797,762 - $939,080
7,541 Added 9.23%
89,253 $10.3 Million
Q1 2021

May 11, 2021
BUY
$108.84 - $128.23 $1.93 Million - $2.27 Million
17,723 Added 27.7%
81,712 $9.79 Million
Q4 2020

Feb 12, 2021
SELL
$105.0 - $114.42 $736,050 - $802,084
-7,010 Reduced 9.87%
63,989 $7.01 Million
Q3 2020

Nov 05, 2020
BUY
$91.64 - $111.29 $154,321 - $187,412
1,684 Added 2.43%
70,999 $7.73 Million
Q2 2020

Sep 22, 2020
SELL
$76.57 - $98.0 $4.15 Million - $5.31 Million
-54,226 Reduced 43.89%
69,315 $6.34 Million
Q1 2020

May 15, 2020
SELL
$62.82 - $91.86 $2.05 Million - $2.99 Million
-32,597 Reduced 20.88%
123,541 $9.75 Million
Q4 2019

Feb 11, 2020
BUY
$78.51 - $87.4 $3.08 Million - $3.42 Million
39,187 Added 33.51%
156,138 $13.6 Million
Q3 2019

Nov 14, 2019
BUY
$81.84 - $88.74 $282,348 - $306,153
3,450 Added 3.04%
116,951 $9.79 Million
Q2 2019

Aug 26, 2019
BUY
$72.88 - $85.0 $8.27 Million - $9.65 Million
113,501 New
113,501 $9.71 Million
Q1 2019

May 15, 2019
SELL
$66.22 - $80.06 $4.33 Million - $5.24 Million
-65,449 Closed
0 $0
Q4 2018

Feb 12, 2019
SELL
$65.56 - $74.27 $166,194 - $188,274
-2,535 Reduced 3.73%
65,449 $4.73 Million
Q3 2018

Oct 09, 2018
SELL
$60.81 - $73.36 $39,161 - $47,243
-644 Reduced 0.94%
67,984 $4.99 Million
Q2 2018

Jul 13, 2018
BUY
$57.57 - $63.54 $265,109 - $292,601
4,605 Added 7.19%
68,628 $4.19 Million
Q1 2018

Apr 30, 2018
BUY
$56.27 - $63.62 $116,647 - $131,884
2,073 Added 3.35%
64,023 $3.84 Million
Q4 2017

Jan 16, 2018
BUY
$53.68 - $57.47 $315,208 - $337,463
5,872 Added 10.47%
61,950 $3.54 Million
Q3 2017

Oct 12, 2017
BUY
$48.06 - $53.64 $2.7 Million - $3.01 Million
56,078
56,078 $2.99 Million

Others Institutions Holding ABT

# of Institutions
3,186
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email